Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 93Carcinoma, Non-Small-Cell Lung 46Neoplasms 33Carcinoma, Renal Cell 24Neoplasm Metastasis 16Colorectal Neoplasms 13Carcinoma, Hepatocellular 12Small Cell Lung Carcinoma 9Prostatic Neoplasms 9Lung Neoplasms 9Diabetes Mellitus, Insulin-Dependent, 12 9Advanced Cancer 9Squamous Cell Carcinoma of Head and Neck 8Uveal Melanoma 7Stomach Neoplasms 7Skin Neoplasms 7Mesothelioma 7Kidney Neoplasms 7Carcinoma, Transitional Cell 7Recurrence 6Pancreatic Neoplasms 6Liver Neoplasms 6Triple Negative Breast Neoplasms 5Sarcoma 5Ovarian Neoplasms 5Head and Neck Neoplasms 5Endometrial Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Solid Tumor 4

Interventions

pembrolizumab 6Proton Therapy 3spartalizumab 2Rosuvastatin Calcium 2Paclitaxel 2Immune Checkpoint Inhibitors 2Cetuximab 2toripalimab 1sotorasib 1peposertib 1osimertinib 1necitumumab 1mirdametinib 1leronlimab 1apatinib 1amivantamab 1abemaciclib 1Valganciclovir 1Trastuzumab 1Therapeutics 1Rifampin 1Radiotherapy 1PankoMab-GEX 1Panitumumab 1Midazolam 1Metformin 1MEK inhibitor I 1Jupiter 1JPT1 protein, human 1Itraconazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Solid Tumor, Adult × Ipilimumab × Clear all
NCT03523819 2024-09-19

A Study of CS1002 in Subjects with Advanced Solid Tumors

CStone Pharmaceuticals

Phase 1 Completed
91 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡